Corona Virus

Democrats dial back drug-pricing plans to win over moderates

It’s a sign the drug industry is bending a potential compromise in manufacturers’ favor after spending more than $171 million lobbying in the first half of this year.Read More

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top